Effect of amantadine on the urinary excretion of some monoamines and metabolites in normal and Parkinsonian subjects.
D000328:Adult; D000368:Aged; D000547:Amantadine / Q000627:therapeutic use*; D002395:Catecholamines / Q000652:urine*; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use; D004298:Dopamine / Q000652:urine; D004837:Epinephrine / Q000652:urine; D005260:Female; D006632:Histamine / Q000652:urine*; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000652:urine; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine / Q000652:urine; D010300:Parkinson Disease / Q000188:drug therapy / Q000378:metabolism* / Q000652:urine; D010648:Phenylacetates / Q000652:urine
D002395:Catecholamines; D010648:Phenylacetates; D006897:Hydroxyindoleacetic Acid; D004295:Dihydroxyphenylalanine; D006632:Histamine; D000547:Amantadine; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine